These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking. Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245 [TBL] [Abstract][Full Text] [Related]
88. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells. Xin X; Hou YT; Li L; Schmiedlin-Ren P; Christman GM; Cheng HL; Bitar KN; Zimmermann EM Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G777-83. PubMed ID: 15068962 [TBL] [Abstract][Full Text] [Related]
89. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. Waterman H; Alroy I; Strano S; Seger R; Yarden Y EMBO J; 1999 Jun; 18(12):3348-58. PubMed ID: 10369675 [TBL] [Abstract][Full Text] [Related]
90. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Maile LA; Capps BE; Ling Y; Xi G; Clemmons DR Endocrinology; 2007 May; 148(5):2435-43. PubMed ID: 17255202 [TBL] [Abstract][Full Text] [Related]
91. Insulin-like growth factor I receptor signaling in transformation by src oncogenes. Valentinis B; Morrione A; Taylor SJ; Baserga R Mol Cell Biol; 1997 Jul; 17(7):3744-54. PubMed ID: 9199308 [TBL] [Abstract][Full Text] [Related]
92. Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways. Kao AW; Waters SB; Okada S; Pessin JE Endocrinology; 1997 Jun; 138(6):2474-80. PubMed ID: 9165038 [TBL] [Abstract][Full Text] [Related]
93. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Wary KK; Mainiero F; Isakoff SJ; Marcantonio EE; Giancotti FG Cell; 1996 Nov; 87(4):733-43. PubMed ID: 8929541 [TBL] [Abstract][Full Text] [Related]
94. A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1. Rakatzi I; Ramrath S; Ledwig D; Dransfeld O; Bartels T; Seipke G; Eckel J Diabetes; 2003 Sep; 52(9):2227-38. PubMed ID: 12941761 [TBL] [Abstract][Full Text] [Related]
95. Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Modan-Moses D; Janicot M; McLenithan JC; Lane MD; Casella SJ Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):825-31. PubMed ID: 9677346 [TBL] [Abstract][Full Text] [Related]
97. p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation. Xi G; Shen X; Clemmons DR J Biol Chem; 2010 Mar; 285(10):6937-51. PubMed ID: 20048152 [TBL] [Abstract][Full Text] [Related]
98. Regulation of igf-I signaling in retinal endothelial cells by hyperglycemia. Miller EC; Capps BE; Sanghani RR; Clemmons DR; Maile LA Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3878-87. PubMed ID: 17652764 [TBL] [Abstract][Full Text] [Related]
99. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation. Xi G; Maile LA; Yoo SE; Clemmons DR J Cell Physiol; 2008 Feb; 214(2):306-15. PubMed ID: 17607710 [TBL] [Abstract][Full Text] [Related]
100. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. Beitner-Johnson D; Blakesley VA; Shen-Orr Z; Jimenez M; Stannard B; Wang LM; Pierce J; LeRoith D J Biol Chem; 1996 Apr; 271(16):9287-90. PubMed ID: 8621590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]